stars 1 stars 2 stars 3

Alyvant uses de-identified patient-level analytics to better understand the nuances of a disease, patterns of physician prescribing, and payer reimbursement. We then turn insights into action through our fit-for-purpose commercial pharmaceutical organization. Our long-range vision is to use technology to reduce the cost of commercializing all medicines, thereby generating savings for the healthcare system at large and helping to ensure that every patient who might benefit from an approved therapy has the opportunity to speak with a physician about appropriate treatment options.

Alyvant, Inc. Questions

The Alyvant, Inc. annual revenue was $6.3 million in 2026.

Alyvant, Inc. is based in New York, New York.

The NAICS codes for Alyvant, Inc. are [325, 3254, 32, 32541].

The SIC codes for Alyvant, Inc. are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users